Trial intelligence / Profile preview

Comparative study of choline alfoscerate as combination therapy with donepezil

KCT0004660Phase 4Recruiting

Sponsor
JW Pharmaceutical Corporation
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of choline alfoscerate, donepezil in confusion, sponsored by JW Pharmaceutical Corporation. Started Nov 2019; status: recruiting.

02

Drugs

choline alfosceratedonepezil
03

Conditions

confusion

Beyond the preview

Go deeper on KCT0004660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call